PsiThera
PrivateLast Round
Series A
Dec 10, 2025
Total Funding Raised
$95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PsiThera is a biotechnology company that develops oral small-molecule medicines for immunology and inflammatory diseases using its proprietary QUAISAR computational intelligence platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PsiThera Comparables
Compare PsiThera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fathom Therapeutics | 89% | |
| Forward Therapeutics | 88% | |
| Genesis Molecular AI | 84% |
PsiThera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 10, 2025 | ||||
| Series A | Dec 10, 2025 |
PsiThera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lightstone Ventures | Series A |
| Eurofarma Ventures | Series A |
| Samsara BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Eric Shaff, formerly of Seres Therapeutics, named new CEO.
- Dec 10, 2025
$48M round completed.
PsiThera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about PsiThera's valuation, stock price, and market status.
Is PsiThera a public or private company?
PsiThera is a private company.
What is the current stock price of PsiThera?
PsiThera is a private company with no public stock price. No recent secondary market data is available.
How much is PsiThera worth (valuation)?
Valuation information for PsiThera is not publicly available.
Can I buy PsiThera stock?
PsiThera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was PsiThera's last funding round?
PsiThera's most recent funding round was Series A on December 10, 2025.
Who are the main investors in PsiThera?
Key investors in PsiThera include Lightstone Ventures, Samsara BioCapital.
Will PsiThera IPO soon?
No public IPO plans have been announced for PsiThera.
How can I track PsiThera secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor PsiThera's secondary market activity and sign up for updates.